Filters close

Not for public release

This news release is embargoed until 18-Mar-2024 2:05 PM EDT Released to reporters: 18-Mar-2024 2:05 PM EDT

A reporter's PressPass is required to access this story until the embargo expires on 18-Mar-2024 2:05 PM EDT The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

access_time Embargo lifts in 2 days
This news release is embargoed until 20-Mar-2024 12:05 AM EDT Released to reporters: 15-Mar-2024 4:05 PM EDT

A reporter's PressPass is required to access this story until the embargo expires on 20-Mar-2024 12:05 AM EDT The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Not for public release

This news release is embargoed until 13-Mar-2024 4:30 PM EDT Released to reporters: 13-Mar-2024 1:05 PM EDT

A reporter's PressPass is required to access this story until the embargo expires on 13-Mar-2024 4:30 PM EDT The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Not for public release

This news release is embargoed until 12-Mar-2024 12:05 AM EDT Released to reporters: 12-Mar-2024 12:05 AM EDT

A reporter's PressPass is required to access this story until the embargo expires on 12-Mar-2024 12:05 AM EDT The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Released: 6-Mar-2024 12:05 PM EST
Loyola Medicine Nephrologist available to discuss study showing Ozempic may slow kidney disease
Loyola Medicine

Loyola Medicine Nephrologist Sylvester Barnes is available to discuss a new study which showed Ozempic cut the risk of kidney disease progression and related health complications in diabetic patients.

Released: 4-Mar-2024 7:05 PM EST
Super Tuesday in an Unprecedented Election Year: Experts Available for Comment
American University

WHAT: Tomorrow, 16 states and one territory will head to the polls in the biggest primary election of this year’s election cycle. As we watch the results come in, American University experts are available to comment on a broad range of issues related to the 2024 presidential elections.   WHEN: March 4, 2024 – ongoing  WHERE: In studio, email, phone, or virtual   WHO:  Experts available for comments include  David Barker, director of the Center for Congressional and Presidential Studies, is an expert on a broad range of topics, including American political parties, campaigns and elections, representation, culture and polarization, ideology and attitudes, information and communication, political institutions, and a wide variety of public policy issues.



close
0.64137